CN Patent

CN101287732A — 囊性纤维化跨膜电导调节剂的调控剂

Assigned to Vertex Pharmaceuticals Inc · Expires 2008-10-15 · 18y expired

What this patent protects

本发明涉及囊性纤维化跨膜电导调节剂(CFTR)的调控剂、其组合物和有关方法。本发明也涉及使用这类调控剂治疗CFTR介导疾病的方法。

USPTO Abstract

本发明涉及囊性纤维化跨膜电导调节剂(CFTR)的调控剂、其组合物和有关方法。本发明也涉及使用这类调控剂治疗CFTR介导疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101287732A
Jurisdiction
CN
Classification
—
Expires
2008-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.